The AI & Digital Health Revolution and the Impact on FDA’s Device and Drug Policies

The rise of artificial intelligence (AI), machine learning (ML), and other digital health technologies has the potential to revolutionize the delivery of healthcare and accelerate the development of new medical products, including both pharmaceuticals and medical devices.

Given the increasing use of these advanced technologies in the medical space, the US Food and Drug Administration (FDA) has been working hard to keep its regulatory policies up to date. This webinar will discuss how FDA regulates digital health technologies (including AI/ML) intended for health-related uses, recent FDA developments related to AI/ML, and FDA’s policies related to the use of AI/ML for pharmaceutical and medical device R&D activities.